Seminars in Oncology
Volume 35 , Pages S31-S38 , April 2008

Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Drs Dean-Colomb and Esteva have no relevant relationships with commercial interests to disclose.

PII: S0093-7754(08)00043-2

doi: 10.1053/j.seminoncol.2008.02.008

Seminars in Oncology
Volume 35 , Pages S31-S38 , April 2008

Article Tools

* Image Usage & Resolution